Kenozole Cream contains Ketoconazole 2% w/w, an imidazole antifungal agent effective in the treatment of various superficial fungal infections. Ketoconazole acts by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased membrane permeability and ultimately fungal cell death. Kenozole Cream is indicated for the topical management of dermatophytosis, candidiasis, and pityriasis versicolor. It is suitable for application on affected skin areas including the body, face, and scalp. The cream formulation ensures adequate skin penetration and prolonged antifungal activity. Kenozole Cream should be applied once or twice daily to the affected area after cleansing and drying the skin, with the duration of treatment typically ranging from 2 to 4 weeks depending on the severity and type of infection. Common adverse effects are generally mild and may include local irritation, burning sensation, or erythema at the application site. Patients should avoid contact with eyes and mucous membranes. Use during pregnancy and lactation should be under medical supervision. Kenozole Cream is contraindicated in individuals with known hypersensitivity to ketoconazole or any of the cream’s excipients. Proper adherence to the prescribed regimen is essential to ensure therapeutic efficacy and prevent recurrence.